Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Percy H Carter. (2013) Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 – 2012. Expert Opinion on Therapeutic Patents 23:5, pages 549-568.
Read now
Read now
Articles from other publishers (20)
Jean-François Bruxelle, Nino Trattnig, Marianne W. Mureithi, Elise Landais & Ralph Pantophlet. (2021) HIV-1 Entry and Prospects for Protecting against Infection. Microorganisms 9:2, pages 228.
Crossref
Crossref
Philip M. Murphy. 2019. Clinical Immunology. Clinical Immunology
157
170.e1
.
Christel A.S. Bergström, William N. Charman & Christopher J.H. Porter. (2016) Computational prediction of formulation strategies for beyond-rule-of-5 compounds. Advanced Drug Delivery Reviews 101, pages 6-21.
Crossref
Crossref
Zack G. Zachariassen, Stefanie Karlshøj, Bengt Erik Haug, Mette M. Rosenkilde & Jon Våbenø. (2015) Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636). Journal of Medicinal Chemistry 58:20, pages 8141-8153.
Crossref
Crossref
Katarzyna A. Trzaska‐Accurso & Pranela Rameshwar. 2015. Stem Cells in Regenerative Medicine. Stem Cells in Regenerative Medicine
487
496
.
Guillaume Pierre Charles George, Federica Pisaneschi, Quang-Dé Nguyen & Eric Ofori Aboagye. (2015) Positron Emission Tomographic Imaging of CXCR4 in Cancer: Challenges and Promises. Molecular Imaging 14:1, pages 7290.2014.00041.
Crossref
Crossref
Claudio F. Sturino, Yves Bousquet, Clint A. James, Patrick DeRoy, Martin Duplessis, Paul J. Edwards, Ted Halmos, Joannie Minville, Louis Morency, Sébastien Morin, Bounkham Thavonekham, Martin Tremblay, Jianmin Duan, Maria Ribadeneira, Michel Garneau, Alex Pelletier, Sonia Tremblay, Louie Lamorte, Richard Bethell, Michael G. Cordingley, Daniel Rajotte & Bruno Simoneau. (2013) Identification of potent and orally bioavailable nucleotide competing reverse transcriptase inhibitors: In vitro and in vivo optimization of a series of benzofurano[3,2-d]pyrimidin-2-one derived inhibitors. Bioorganic & Medicinal Chemistry Letters 23:13, pages 3967-3975.
Crossref
Crossref
Maarten BuitendijkSusan K. EszterhasAlexandra L. Howell. (2013) Gardiquimod: A Toll-Like Receptor-7 Agonist That Inhibits HIV Type 1 Infection of Human Macrophages and Activated T Cells. AIDS Research and Human Retroviruses 29:6, pages 907-918.
Crossref
Crossref
Anne Steen, Stefanie Thiele, Dong Guo, Lærke S. Hansen, Thomas M. Frimurer & Mette M. Rosenkilde. (2013) Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7. Journal of Biological Chemistry 288:18, pages 12511-12521.
Crossref
Crossref
Clint A. James, Patrick DeRoy, Martin Duplessis, Paul J. Edwards, Teddy Halmos, Joannie Minville, Louis Morency, Sébastien Morin, Bruno Simoneau, Martin Tremblay, Richard Bethell, Michael Cordingley, Jianmin Duan, Louie Lamorte, Alex Pelletier, Daniel Rajotte, Patrick Salois, Sonia Tremblay & Claudio F. Sturino. (2013) Nucleotide competing reverse transcriptase inhibitors: Discovery of a series of non-basic benzofurano[3,2-d]pyrimidin-2-one derived inhibitors. Bioorganic & Medicinal Chemistry Letters 23:9, pages 2781-2786.
Crossref
Crossref
Nicholas A. Meanwell, Stanley V. D'Andrea, Christopher W. Cianci, Ira B. Dicker, Kap-Sun Yeung, Makonen Belema & Mark Krystal. 2013. Drug Discovery. Drug Discovery
439
515
.
Jelena Malogajski, Ivan Brankovic, Stephan P. Verweij, Elena Ambrosino, Michiel A. van Agtmael, Angela Brand, Sander Ouburg & Servaas A. Morré. (2013)
Translational Potential into Health Care of Basic Genomic and Genetic Findings for Human Immunodeficiency Virus,
Chlamydia trachomatis
, and Human Papilloma Virus
. BioMed Research International 2013, pages 1-10.
Crossref
Crossref
Jignesh Mungalpara, Zack G. Zachariassen, Stefanie Thiele, Mette M. Rosenkilde & Jon Våbenø. (2013) Structure–activity relationship studies of the aromatic positions in cyclopentapeptide CXCR4 antagonists. Organic & Biomolecular Chemistry 11:47, pages 8202.
Crossref
Crossref
Junwon Kim, Jeongjin Kwon, Doohyun Lee, Suyeon Jo, Dong-Sik Park, Jihyun Choi, Eunjung Park, Jong Yeon Hwang, Yoonae Ko, Inhee Choi, Moon Kyeong Ju, JiYe Ahn, Junghwan Kim, Sung-Jun Han, Tae-Hee Kim, Jonathan Cechetto, Jiyoun Nam, Sujin Ahn, Peter Sommer, Michel Liuzzi, Zaesung No & Jinhwa Lee. (2013) Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors. Bioorganic & Medicinal Chemistry Letters 23:1, pages 153-157.
Crossref
Crossref
Philip M. Murphy. 2013. Clinical Immunology. Clinical Immunology
136
148
.
Jignesh Mungalpara, Stefanie Thiele, Øystein Eriksen, Johann Eksteen, Mette M. Rosenkilde & Jon Våbenø. (2012) Rational Design of Conformationally Constrained Cyclopentapeptide Antagonists for C-X-C Chemokine Receptor 4 (CXCR4). Journal of Medicinal Chemistry 55:22, pages 10287-10291.
Crossref
Crossref
Hela SaidiMohammad-Ali JenabianLaurent Belec. (2012) Understanding Factors That Modulate HIV Infection at the Female Genital Tract Mucosae for the Rationale Design of Microbicides. AIDS Research and Human Retroviruses 28:11, pages 1485-1497.
Crossref
Crossref
Hakimeh Mohammadi & Dorothee Bienzle. (2012) Pharmacological Inhibition of Feline Immunodeficiency Virus (FIV). Viruses 4:5, pages 708-724.
Crossref
Crossref
Shinya Oishi & Nobutaka Fujii. (2012) Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4). Organic & Biomolecular Chemistry 10:30, pages 5720.
Crossref
Crossref
Joeri Kuil, Tessa Buckle & Fijs W. B. van Leeuwen. (2012) Imaging agents for the chemokine receptor 4 (CXCR4). Chemical Society Reviews 41:15, pages 5239.
Crossref
Crossref